53 filings
Page 2 of 3
8-K
94yesalq7nr u3
15 Jun 23
Entry into a Material Definitive Agreement
4:10pm
8-K
rglgpp 08l6x1izjx3
12 Jun 23
Regulation FD Disclosure
7:05am
8-K
6n1u804hk mfywm4
8 Jun 23
Entry into a Material Definitive Agreement
7:00am
8-K
nimlyolcsibys9
15 May 23
Entry into a Material Definitive Agreement
7:00am
8-K
b1b36qtqt7 8u7r366
20 Apr 23
Regulation FD Disclosure
7:05am
8-K
puu7hcs
5 Apr 23
Entry into a Material Definitive Agreement
4:30pm
8-K
8qkzvtt
8 Mar 23
Entry into a Material Definitive Agreement
4:30pm
8-K
xhz 6jkmhqwi0c
21 Feb 23
TriSalus Life Sciences Appoints James Alecxih to Lead Device Technology Business
7:05am
8-K
qqnp76sq
16 Feb 23
Regulation FD Disclosure
7:05am
8-K
0uh 2vri2z6h6qhd
21 Dec 22
Regulation FD Disclosure
9:01am
8-K
bfinrj xj
16 Dec 22
Entry into a Material Definitive Agreement
6:14pm
8-K
ynif2r xtiwx
15 Dec 22
TriSalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) Clinical Trial Progress and Pre-clinical Research Developments
9:00am
8-K
rh3qh37y48kcsdkbg
7 Dec 22
MedTech Acquisition Corporation Announces Adjournment of its Special Meeting in lieu of an Annual Meeting of Stockholders
9:50pm
8-K
jsoa0v0e5bs4kcqbrx4
2 Dec 22
Entry into a Material Definitive Agreement
4:55pm
8-K
4uagc yas21m9xf1n4
21 Nov 22
TriSalus Life Sciences Provides Updates on Pressure-Enabled Regional Immuno-Oncology™ (PERIO™) 01 and 02 Clinical Studies
7:05am
8-K
dmh t43un4hxspl
14 Nov 22
Regulation FD Disclosure
4:32pm
8-K
tlg1e77268vu9o
14 Nov 22
TriSalus Life Sciences to Become Publicly Traded Through Merger with MedTech Acquisition Corporation
7:05am
8-K
3dumv7f9otd
1 Nov 22
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:01pm
8-K
bo0v 9cmt
26 May 22
Entry into a Material Definitive Agreement
4:52pm
8-K
w4ejt7sb3cvnf9x0
10 Mar 22
MedTech Acquisition Corporation and Memic Innovative Surgery Ltd. Mutually Agree to Terminate Business Combination
8:00am